ECSP18081922A - Apósitos para heridas modificados - Google Patents

Apósitos para heridas modificados

Info

Publication number
ECSP18081922A
ECSP18081922A ECSENADI201881922A ECDI201881922A ECSP18081922A EC SP18081922 A ECSP18081922 A EC SP18081922A EC SENADI201881922 A ECSENADI201881922 A EC SENADI201881922A EC DI201881922 A ECDI201881922 A EC DI201881922A EC SP18081922 A ECSP18081922 A EC SP18081922A
Authority
EC
Ecuador
Prior art keywords
wounds
chronic
compositions
kits
compounds
Prior art date
Application number
ECSENADI201881922A
Other languages
English (en)
Inventor
Lucy Ballamy
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of ECSP18081922A publication Critical patent/ECSP18081922A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/56—Wetness-indicators or colourants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las formas de realización descritas en la presente se refieren a compuestos para la detección de heridas, por ejemplo, heridas crónicas o heridas infectadas, que incluyen composiciones, sustratos, kits, materiales de apósitos y artículos, y sistemas que contengan dichos compuestos. Formas de realización adicionales se refieren a métodos de uso de estas composiciones, kits y sistemas en ensayos de diagnóstico, y en el diagnóstico y/o detección de heridas crónicas o infectadas en función de la conversión enzimática de sustratos específicos que están contenidos en las composiciones. Formas de realización adicionales se refieren a métodos de caracterización de heridas en función de la expresión de una pluralidad de marcadores y de uso de dicha información para tratar y controlar pacientes que padecen heridas crónicas o infectadas, y para hacerles seguimiento.
ECSENADI201881922A 2016-03-30 2018-10-30 Apósitos para heridas modificados ECSP18081922A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662315567P 2016-03-30 2016-03-30

Publications (1)

Publication Number Publication Date
ECSP18081922A true ECSP18081922A (es) 2019-02-28

Family

ID=59965163

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201881922A ECSP18081922A (es) 2016-03-30 2018-10-30 Apósitos para heridas modificados

Country Status (19)

Country Link
US (3) US20190307904A1 (es)
EP (1) EP3436012B1 (es)
JP (2) JP7394526B2 (es)
KR (1) KR20180132093A (es)
CN (1) CN109219436B (es)
AR (1) AR108054A1 (es)
AU (1) AU2017244116C1 (es)
BR (1) BR112018070191A2 (es)
CL (1) CL2018002782A1 (es)
CO (1) CO2018011720A2 (es)
EC (1) ECSP18081922A (es)
ES (1) ES2968013T3 (es)
IL (1) IL262011A (es)
MX (1) MX2018011811A (es)
PL (1) PL3436012T3 (es)
SG (1) SG11201808528VA (es)
TW (1) TW201806625A (es)
UY (1) UY37176A (es)
WO (1) WO2017173026A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
ES2964692T3 (es) 2015-04-28 2024-04-09 Convatec Technologies Inc Nanofibras antibacterianas
CA3019436A1 (en) 2016-03-30 2017-10-05 Qualizyme Diagnostics Gmbh & Co Kg Detecting microbial infection in wounds
SG11201808528VA (en) 2016-03-30 2018-10-30 Convatec Technologies Inc Modified wound dressings
CA3092171C (en) 2017-10-06 2025-04-01 Eluciderm Inc. COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS
MX2020004744A (es) 2017-11-09 2020-08-13 11 Health And Tech Limited Sistema y metodo de monitoreo de ostomia.
SG11202109443QA (en) * 2018-11-02 2021-09-29 Fount Bio Inc Crosslinked materials
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
SG11202112292QA (en) * 2019-06-03 2021-12-30 Convatec Ltd Methods and devices to disrupt and contain pathogens
US20220354779A1 (en) * 2019-09-19 2022-11-10 Ohio State Innovation Foundation Nanofiber- and nanowhisker-based transfection platforms
WO2021087008A1 (en) * 2019-10-28 2021-05-06 Brown University Bacterial beta-lactamase responsive hydrogels
IL292994A (en) * 2019-11-14 2022-07-01 Bruin Biometrics Llc Ultrasound imaging
WO2021097079A1 (en) 2019-11-15 2021-05-20 Bruin Biometrics, Llc Spectral imaging
CN114980813B (zh) 2019-12-23 2025-05-27 康沃特克有限公司 用于检测伤口感染状态的护理点装置
CN111012944A (zh) * 2019-12-30 2020-04-17 山东星之诚生物科技有限公司 一种基于藻酸盐和透明质酸的液体敷料及其制备方法
CN111330069A (zh) * 2020-03-09 2020-06-26 蔡钧 一种外用敷料及其制备方法和应用
AU2021361238A1 (en) 2020-10-15 2023-05-25 Convatec Technologies Inc. Ostomy systems and methods
CN112358646B (zh) * 2020-10-20 2023-03-31 湖北大学 一种荧光水凝胶敷料的制备方法及其应用
CN112341638B (zh) * 2020-11-05 2022-07-15 云南师范大学 一种多孔结构水凝胶材料及其制备与应用
CN112370567B (zh) * 2020-11-19 2023-05-16 南方医科大学南方医院 一种具有抗菌消炎功能的水凝胶活性敷料
CN112980003B (zh) * 2021-04-16 2022-06-28 中国药科大学 一种基于天然多糖型抗菌水凝胶、制备方法及用途
CN114470297B (zh) * 2021-12-20 2022-09-13 山西医科大学 一种糖触发响应型创伤快愈型敷料及其制备方法
CN114835722B (zh) * 2022-05-12 2023-03-21 大连理工大学 一种用于测定农药残留的丙氨酸氨基肽酶荧光探针的合成与应用
CN115920119B (zh) * 2022-11-18 2024-10-01 常州大学 明胶酶响应性光热载氧水凝胶伤口敷料及其制备方法
CN116284492B (zh) * 2022-12-31 2025-09-02 上海交通大学 多糖基高分子交联剂、多糖基生物材料及制备方法与应用
GB2636539A (en) * 2023-03-16 2025-06-25 Univ Of Sunderland Wound dressing
CN118806965A (zh) * 2023-04-17 2024-10-22 上海交通大学 高效止血材料及其制备方法与应用
WO2024231986A1 (ja) * 2023-05-08 2024-11-14 国立大学法人金沢大学 セルロース誘導体及びその製造方法、並びにセルロース誘導体を含む組成物
CN117731829B (zh) * 2024-02-21 2024-05-10 浙江格物致知生物科技有限公司 一种医用凝胶敷料及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
DE3783073T2 (de) 1986-04-22 1993-04-29 Ajinomoto Kk Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.
DE69229174T2 (de) 1991-08-23 1999-09-16 Molecular Probes, Inc. Verwendung von haloalkylderivaten von reportermolekülen zur analyse der metabolischen aktivität in zellen
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
GB2381452B (en) 2001-11-05 2005-08-10 Johnson & Johnson Medical Ltd Wound monitoring
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7544640B2 (en) 2002-12-10 2009-06-09 Halliburton Energy Services, Inc. Zeolite-containing treating fluid
KR100876518B1 (ko) * 2002-12-26 2008-12-31 오츠카 가가쿠 가부시키가이샤 당사슬 아스파라긴 유도체 및 그의 제조방법
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
MXPA05007151A (es) 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Polimeros terminados en maleimida hidroliticamente estables.
WO2006080951A2 (en) * 2004-07-01 2006-08-03 Yale University Targeted and high density drug loaded polymeric materials
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
AU2010251237B2 (en) 2009-05-18 2015-12-10 Mega Patent Exploitation Gmbh Method for detecting a wound infection
EP2555784B1 (en) 2010-04-07 2015-06-24 Comvita New Zealand Limited Honey-based gel composition
GB201012333D0 (en) 2010-07-22 2010-09-08 Convatec Technologies Inc Fibres, a process for producing such fibres and a wound dressing incorporating them
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
WO2012074509A1 (en) 2010-11-30 2012-06-07 Avery Dennison Corporation Sensing patch applications
EP2671081A2 (en) * 2011-01-31 2013-12-11 Systagenix Wound Management IP Co. BV. Wound prognosis
FR2977491B1 (fr) 2011-07-05 2013-07-26 Melvita Production Composition cosmetique comprenant un melange de miels
US20120183585A1 (en) * 2012-02-25 2012-07-19 Rassoul Dinarvand Gel based wound dressing and a method of synthesizing the same
US9139718B2 (en) * 2012-12-20 2015-09-22 E I Du Pont De Nemours And Company Preparation of poly alpha-1,3-glucan ethers
US9089614B2 (en) 2012-12-21 2015-07-28 Bioalliance C.V. Hydrophilic self-immolative linkers and conjugates thereof
WO2014172040A1 (en) * 2013-03-15 2014-10-23 Synedgen Inc. Compositions and methods of use for wound healing
CA2908136C (en) 2013-03-30 2021-06-29 Glytech, Inc. Sugar chain-polypeptide complex
US20150143467A1 (en) 2013-11-19 2015-05-21 Intel-Ge Care Innovations Llc System and method for facilitating communication between a web application and a local peripheral device through a native service
EP3423011B1 (en) 2016-03-01 2020-07-08 KCI Licensing, Inc. Drape for use with medical therapy systems
SG11201808488XA (en) 2016-03-30 2018-10-30 Convatec Technologies Inc Detecting microbial infections in wounds
SG11201808528VA (en) 2016-03-30 2018-10-30 Convatec Technologies Inc Modified wound dressings

Also Published As

Publication number Publication date
MX2018011811A (es) 2019-08-21
JP2022065128A (ja) 2022-04-26
CN109219436B (zh) 2025-05-23
AU2017244116C1 (en) 2023-06-01
JP7395630B6 (ja) 2024-01-23
JP7395630B2 (ja) 2023-12-11
CO2018011720A2 (es) 2018-11-13
ES2968013T3 (es) 2024-05-06
EP3436012A1 (en) 2019-02-06
CA3019548A1 (en) 2017-10-05
EP3436012B1 (en) 2023-09-20
US12257323B2 (en) 2025-03-25
US11865192B2 (en) 2024-01-09
TW201806625A (zh) 2018-03-01
CN109219436A (zh) 2019-01-15
JP7394526B2 (ja) 2023-12-08
KR20180132093A (ko) 2018-12-11
US20240123091A1 (en) 2024-04-18
EP3436012C0 (en) 2023-09-20
AU2017244116A1 (en) 2018-11-15
CL2018002782A1 (es) 2019-03-15
AU2017244116B2 (en) 2023-03-02
US20210275693A1 (en) 2021-09-09
AR108054A1 (es) 2018-07-11
EP3436012A4 (en) 2019-10-23
WO2017173026A1 (en) 2017-10-05
SG11201808528VA (en) 2018-10-30
PL3436012T3 (pl) 2024-04-08
US20190307904A1 (en) 2019-10-10
IL262011A (en) 2018-10-31
UY37176A (es) 2017-10-31
BR112018070191A2 (pt) 2019-01-29
JP2019509853A (ja) 2019-04-11

Similar Documents

Publication Publication Date Title
ECSP18081922A (es) Apósitos para heridas modificados
ECSP18081954A (es) Detección de infección microbiana en heridas
BR102018069950A8 (pt) Curativos extensíveis
BR112018075288A2 (pt) métodos para diagnóstico de infecções bacterianas e virais
CL2016001364A1 (es) Moduladores de ror gamma (rory)
AR108056A1 (es) Detección de infecciones microbianas en heridas
CL2018000107A1 (es) Moléculas de anticuerpo que se unen a cd79
BR112017028318A2 (pt) compostos antibacterianos
CL2019001836A1 (es) Anticuerpos humanos a la toxina hemolisina a de s. aureus.
BR112015013123A2 (pt) inibidores de beta-lactamase
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
MX2019005156A (es) Leucocidinas de staphylococcus aureus, composiciones terapeuticas y usos de las mismas.
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
BR112016015449A8 (pt) compostos inibidores terapêuticos, composição farmacêutica os compreendendo e uso dos mesmos
CL2013002898A1 (es) Compuestos derivados de benceno sustituido con arilo o heteroarilo; composicion farmaceutica que los comprende y uso en el tratamiento del cancer.
BR112015023403A2 (pt) dispositivos adesivos de fechamento de uso prolon-gado com alta capacidade liberação fácil
BR112015017241A8 (pt) composto, composição farmacêutica, uso do composto e da composição farmacêutica e kit
BR112018012177A2 (pt) ?moduladores de hidantação de canais kv 3?
CL2016000568A1 (es) Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas.
BR112022003799A2 (pt) Compostos antibacterianos
MX378834B (es) El uso de un inhibidor de c1-esterasa para el tratamiento del rechazo mediado por anticuerpos en pacientes con trasplante de órganos.
CL2015003752A1 (es) Inhibidores de replicación viral, su proceso de preparación y sus uso terapeutico
CL2016001054A1 (es) Compuestos para el tratamiento de diabetes y complicaciones de enfermedades derivadas de la misma
BR112014018709A8 (pt) Composições e efetores de beta-arrestina e métodos de uso dos mesmos
BR112018010596A2 (pt) anticorpos para cgrp e usos dos mesmos